Nakamura, T <br/><br/>
Effect of pioglitazone on dyslipidemia in hemodialysis patients with type 2 diabetes.  [electronic resource] 

 -  Renal failure  Nov 2001 
 - 863-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0886-022X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cholesterol, HDL--blood<br/>Diabetes Mellitus, Type 2--complications<br/>Female<br/>Glyburide--therapeutic use<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hyperlipidemias--blood<br/>Hypoglycemic Agents--therapeutic use<br/>Kidney Failure, Chronic--complications<br/>Male<br/>Middle Aged<br/>Pioglitazone<br/>Renal Dialysis<br/>Thiazoles--therapeutic use<br/>Thiazolidinediones<br/>Triglycerides--blood